Neonatal Abstinence Syndrome

Pediatric Annals
|January 14, 2020
PubMed

Insights

Neonatal Abstinence Syndrome (NAS) affects many infants exposed to opioids. Standardized care and validated assessment tools are needed to improve management and infant outcomes.

Area of Science:

  • Neonatal care
  • Pharmacology
  • Public Health

Background:

  • Opioid use has increased significantly, leading to more in-utero exposures.
  • Infants exposed to opioids in-utero are at high risk for Neonatal Abstinence Syndrome (NAS).
  • NAS management requires hospitalization for 55% to 94% of affected infants.

Observation:

  • Current assessment tools like the Finnegan scoring system are not validated and can be difficult to use.
  • There is a lack of standardized care plans for NAS management.
  • Both non-pharmacologic and pharmacologic interventions lack standardization across institutions.

Findings:

  • Infants with NAS require careful monitoring for withdrawal symptoms.
  • Determining the need for and type of treatment is crucial for NAS management.
  • Preparing infants for discharge requires stabilization and appropriate follow-up.

Implications:

  • Development of standardized care plans for NAS is essential.
  • Validated and user-friendly assessment tools are needed for accurate NAS diagnosis.
  • Improved management strategies can enhance outcomes for infants with NAS and their families.

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
930
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.0K
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.5K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
341
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K